Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Temporary Marketing Permit Applications, 47793-47794 [2020-17168]
Download as PDF
<![CDATA[
47793
Federal Register / Vol. 85, No. 152 / Thursday, August 6, 2020 / Notices
Persons other than the registrants may
sell, distribute, or use existing stocks of
canceled products until supplies are
exhausted, provided that such sale,
distribution, or use is consistent with
the terms of the previously approved
labeling on, or that accompanied, the
canceled products.
Dated: July 28, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation
Division, Office of Pesticide Programs.
[FR Doc. 2020–17114 Filed 8–5–20; 8:45 am]
BILLING CODE 6560–50–P
Receiver for each of the following
insured depository institutions, was
charged with the duty of winding up the
affairs of the former institutions and
liquidating all related assets. The
Receiver has fulfilled its obligations and
made all dividend distributions
required by law.
FEDERAL DEPOSIT INSURANCE
CORPORATION
Authority: 7 U.S.C. 136 et seq.
Notice of Termination of Receiverships
The Federal Deposit Insurance
Corporation (FDIC or Receiver), as
NOTICE OF TERMINATION OF RECEIVERSHIPS
Fund
Receivership name
City
10145 .................
10170 .................
United Security Bank ...........................................................
Town Community Bank & Trust ..........................................
Sparta ...................................................
Antioch .................................................
The Receiver has further irrevocably
authorized and appointed FDICCorporate as its attorney-in-fact to
execute and file any and all documents
that may be required to be executed by
the Receiver which FDIC-Corporate, in
its sole discretion, deems necessary,
including but not limited to releases,
discharges, satisfactions, endorsements,
assignments, and deeds. Effective on the
termination dates listed above, the
Receiverships have been terminated, the
Receiver has been discharged, and the
Receiverships have ceased to exist as
legal entities.
(Authority: 12 U.S.C. 1819)
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on August 3,
2020.
James P. Sheesley,
Acting Assistant Executive Secretary.
[FR Doc. 2020–17208 Filed 8–5–20; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
ACTION:
Notice.
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HEALTHCARE
INFORMATION TECHNOLOGY
RESEARCH (HITR) 2020/10–ZHS1
SUMMARY:
VerDate Sep<11>2014
17:13 Aug 05, 2020
Jkt 250001
HSR–F (01).’’ This SEP meeting will be
closed to the public.
DATES: August 26, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301)427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘HEALTHCARE INFORMATION
TECHNOLOGY RESEARCH (HITR)
2020/10–ZHS1 HSR–F (01)’’ is to be
reviewed and discussed at this meeting.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
State
Termination
date
GA
IL
8/1/2020
8/1/2020
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: August 3, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–17224 Filed 8–5–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0424]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Temporary
Marketing Permit Applications
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments
(including recommendations) on the
collection of information by September
8, 2020.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
SUMMARY:
E:\FR\FM\06AUN1.SGM
06AUN1
47794
Federal Register / Vol. 85, No. 152 / Thursday, August 6, 2020 / Notices
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. The OMB
control number for this information
collection is 0910–0133. Also include
the FDA docket number found in
brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Temporary Marketing Permit
Applications—21 CFR 130.17(c) and (i)
OMB Control Number 0910–0133—
Extension
Section 401 of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 341) (FD&C
Act) directs FDA to issue regulations
establishing definitions and standards of
identity for food. Under section 403(g)
of the FD&C Act (21 U.S.C. 343(g)), a
food that is subject to a definition and
standard of identity prescribed by
regulation is misbranded if it does not
conform to such definition and standard
of identity. Section 130.17 (21 CFR
130.17) provides for the issuance by
FDA of temporary marketing permits
that enable the food industry to test
consumer acceptance and measure the
technological and commercial feasibility
in interstate commerce of experimental
packs of food that deviate from
applicable definitions and standards of
identity. Section 130.17(c) enables the
Agency to monitor the manufacture,
labeling, and distribution of
experimental packs of food that deviate
from applicable definitions and
standards of identity. The information
so obtained can be used in support of
a petition to establish or amend the
applicable definition or standard of
identity to provide for the variations.
Section 130.17(i) specifies the
information that a firm must submit to
FDA to obtain an extension of a
temporary marketing permit.
Description of Respondents:
Respondents to this collection of
information include private sector
businesses including institutional and/
or industrial customers and food
industry members such as
manufacturers, packers, or distributors
desiring to apply for a temporary
marketing permit or permit extension.
In the Federal Register of April 16,
2020 (85 FR 21247), we published a 60day notice requesting public comment
on the proposed collection of
information. No comments were
received.
We estimate the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
21 CFR section; activity
Number of
responses
per
respondent
Total annual
responses
Total hours
130.17(c); Request for temporary marketing permit ...........
130.17(i); Request to extend marketing permit ...................
13
1
2
2
26
2
25
2
650
4
Total ..............................................................................
........................
........................
........................
........................
654
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
Dated: July 31, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020–17168 Filed 8–5–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0312]
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on reporting
requirements associated with extralabel
drug use in animals.
SUMMARY:
Submit either electronic or
written comments on the collection of
information by October 5, 2020.
DATES:
jbell on DSKJLSW7X2PROD with NOTICES
Average
burden
per response
(in hours)
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Extralabel Drug
Use in Animals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Sep<11>2014
17:13 Aug 05, 2020
Jkt 250001
You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before October 5,
2020. The https://www.regulations.gov
ADDRESSES:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of October 5, 2020. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 85, Number 152 (Thursday, August 6, 2020)]
[Notices]
[Pages 47793-47794]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17168]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0424]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Temporary Marketing
Permit Applications
AGENCY: Food and Drug Administration, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Submit written comments (including recommendations) on the
collection of information by September 8, 2020.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to https://
[[Page 47794]]
www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0133. Also include the FDA docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-5733,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Temporary Marketing Permit Applications--21 CFR 130.17(c) and (i)
OMB Control Number 0910-0133--Extension
Section 401 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
341) (FD&C Act) directs FDA to issue regulations establishing
definitions and standards of identity for food. Under section 403(g) of
the FD&C Act (21 U.S.C. 343(g)), a food that is subject to a definition
and standard of identity prescribed by regulation is misbranded if it
does not conform to such definition and standard of identity. Section
130.17 (21 CFR 130.17) provides for the issuance by FDA of temporary
marketing permits that enable the food industry to test consumer
acceptance and measure the technological and commercial feasibility in
interstate commerce of experimental packs of food that deviate from
applicable definitions and standards of identity. Section 130.17(c)
enables the Agency to monitor the manufacture, labeling, and
distribution of experimental packs of food that deviate from applicable
definitions and standards of identity. The information so obtained can
be used in support of a petition to establish or amend the applicable
definition or standard of identity to provide for the variations.
Section 130.17(i) specifies the information that a firm must submit to
FDA to obtain an extension of a temporary marketing permit.
Description of Respondents: Respondents to this collection of
information include private sector businesses including institutional
and/or industrial customers and food industry members such as
manufacturers, packers, or distributors desiring to apply for a
temporary marketing permit or permit extension.
In the Federal Register of April 16, 2020 (85 FR 21247), we
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
We estimate the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total annual burden per
21 CFR section; activity respondents responses per responses response (in Total hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
130.17(c); Request for temporary 13 2 26 25 650
marketing permit...............
130.17(i); Request to extend 1 2 2 2 4
marketing permit...............
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 654
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Based on a review of the information collection since our last
request for OMB approval, we have made no adjustments to our burden
estimate.
Dated: July 31, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020-17168 Filed 8-5-20; 8:45 am]
BILLING CODE 4164-01-P
